TerminatedNCT05144685
A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic
Device studyAges 18+United StatesSuicide prevention
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Denver and 5 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 7, 2022
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 356
- Sponsor
- Oui Therapeutics, Inc.
- Sponsor type
- Biotech company
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, DEVICE
- Study phase
- Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT05144685
- Official title
Show the full official title
A Randomized, Double Blind Controlled Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic for Individuals With Suicidal Ideation and/or Suicide Attempts
Recruitment & locations
TerminatedDenver · New Haven · Omaha
3 more locations
- Glen Oaks
- Cincinnati
- Columbus
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Oui Therapeutics, Inc.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as terminated.
